NASDAQ:CLVS - Clovis Oncology Earnings Date, Estimates & History

Get Started

$17.41 +1.05 (+6.42 %)

(As of 05/21/2019 04:00 PM ET)

Previous Close$16.36

Today's Range$16.63 - $17.61

52-Week Range$11.50 - $51.76

Volume1.52 million shs

Average Volume1.76 million shs

Market Capitalization$922.82 million

P/E RatioN/A

Dividend YieldN/A

Beta1.89

Clovis Oncology (NASDAQ:CLVS) Earnings History and Estimates Chart

Earnings by Quarter for Clovis Oncology (NASDAQ:CLVS)

Clovis Oncology (NASDAQ:CLVS) Earnings Estimates

2019 EPS Consensus Estimate: ($6.86)
2020 EPS Consensus Estimate: ($5.90)

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2019	2	($1.89)	($1.70)	($1.80)
Q2 2019	2	($1.79)	($1.60)	($1.70)
Q3 2019	2	($1.85)	($1.59)	($1.72)
Q4 2019	3	($1.93)	($1.42)	($1.65)
Q1 2020	1	($1.57)	($1.57)	($1.57)
Q2 2020	1	($1.58)	($1.58)	($1.58)
Q3 2020	1	($1.49)	($1.49)	($1.49)
Q4 2020	1	($1.26)	($1.26)	($1.26)

Clovis Oncology (NASDAQ CLVS) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Reported EPS	GAAP EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
8/7/2019 (Estimated)
5/7/2019	3/31/2019	($1.80)	($1.63)	($1.63)	$32.10 million	$33.12 million	View	N/A
2/26/2019	Q4 2018	($1.68)	($1.88)	($1.88)	$30.46 million	$30.40 million	View	Listen
10/30/2018	9/30/2018	($1.60)	($1.71)	($1.71)	$30.11 million	$22.76 million	View	N/A
8/1/2018	Q2 2018	($1.38)	($1.94)	($1.94)	$22.44 million	$23.76 million	View	N/A
5/8/2018	Q1 2018	($1.36)	($1.54)	($1.54)	$18.34 million	$18.50 million	View	N/A
2/26/2018	Q4 2017	($1.29)	($1.04)	($1.50)	$19.42 million	$17.04 million	View	Listen
11/1/2017	Q3 2017	($1.18)	($1.24)	($1.24)	$21.12 million	$16.81 million	View	N/A
8/2/2017	Q2 2017	($1.27)	($1.29)	$1.30	$13.07 million	$14.62 million	View	Listen
5/3/2017	Q1 2017	($1.43)	($1.33)	($1.33)	$6.04 million	$7.05 million	View	Listen
2/22/2017	Q416	($1.65)	($1.83)	($1.83)		$0.08 million	View	Listen
11/3/2016	Q316	($1.95)	($1.70)	($1.70)			View	Listen
8/8/2016	Q216	($2.13)	($2.07)	($0.77)			View	Listen
5/5/2016	Q116	($2.39)	($2.17)	($2.17)			View	Listen
2/25/2016	Q415	($2.39)	($2.23)	($1.34)			View	Listen
11/5/2015	Q315	($2.07)	($2.62)	($2.62)			View	Listen
8/6/2015	Q215	($2.11)	($2.10)	($2.10)	$1.17 million		View	Listen
5/6/2015	Q115	($1.78)	($1.86)	($1.86)	$13.60 million		View	Listen
2/25/2015	Q414	($1.41)	($1.62)	($1.62)			View	Listen
11/6/2014	Q314	($1.03)	($1.17)	($1.17)			View	Listen
8/7/2014	Q214	($0.93)	($1.03)	($1.03)		$13.60 million	View	Listen
5/8/2014	Q114	($0.85)	($0.91)	($0.91)		$13.60 million	View	Listen
2/27/2014	Q4 2013	($0.75)	($0.92)	($0.92)			View	Listen
10/31/2013	Q3 2013	($0.63)	($0.68)	($0.68)			View	Listen
8/1/2013	Q2 2013	($0.69)	($0.72)	($0.72)			View	Listen
5/7/2013	Q1 2013	($0.60)	($0.60)	($0.60)			View	Listen
2/28/2013	Q4 2012	($0.76)	($0.81)	($0.81)			View	N/A
11/5/2012	Q3 2012	($0.68)	($0.71)	($0.71)			View	N/A
8/8/2012	Q2 2012	($0.61)	($0.61)	($0.61)			View	N/A
5/8/2012	Q1 2012	($0.81)	($0.74)	($0.62)			View	N/A
3/7/2012	Q4 2011	($0.79)	($1.30)	($1.30)			View	N/A

(Earnings results data provided by Zacks Investment Research)

This page was last updated on 5/21/2019 by MarketBeat.com Staff

Featured Article: Limitations of the P/E Growth ratio